Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075
Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...
Read More...